Digital Health Startups

Lume develops a wearable sweat sensor that monitors hormonal changes and health metrics throughout the day. The device is designed for individuals seeking continuous health insights beyond traditional periodic checkups.

1 investor

InvolveXR offers an AI-enabled virtual reality training platform for healthcare education that combines immersive simulations with AI-assisted assessments to help institutions scale personalized learning and clinical skill development.

1 investor

Lumi is a practice-management platform for therapists, psychologists, and coaches that automates booking, session reminders, invoicing, and payment collection while storing sensitive client data in a GDPR-compliant, encrypted system. It offers an online booking page, calendar integration, and automated client communication tailored to therapeutic practices.

1 investor

Lumia Care operates a healthcare conglomerate that provides aged care, disability support, hospital-level in-home care, and nursing workforce services across Australia. The company serves individuals, families, and healthcare institutions seeking personalized and clinical care services to support independence and wellbeing.

1 investor

Somatus provides value-based kidney and heart care, offering individualized clinical, emotional, and social support to patients while partnering with providers and health plans to improve outcomes and lower costs. Its local, hands-on health support teams help patients manage their conditions at home.

1 investor

LuminX develops an AI-powered dental probing device that lets a single practitioner perform full-mouth periodontal probing and automatic charting, capturing pocket depths, bleeding, recession, and mobility in real time. The technology serves dentists, periodontists, and hygienists to diagnose and track gum disease.

1 investor

Lumonus builds an AI-powered oncology intelligence layer that acts as a workflow assistant for radiation oncology teams, integrating with major EMR, OIS, and TPS systems. Its products cover learning, automation, and knowledge management to speed up processes such as contouring and treatment planning while reducing errors.

1 investor

Lumos Diagnostics develops rapid point-of-care diagnostic tests and digital reader platforms for healthcare professionals, targeting infectious and inflammatory diseases. The company offers both customized assay development services and proprietary branded diagnostic solutions.

1 investor

Lunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.

1 investor

Lunalta develops an AI-powered platform for perimenopause and menopause care, connecting women with personalized health guidance and qualified healthcare providers. The platform delivers 24/7 support through AI agents accessible via text and voice across iOS, Android, and web.

1 investor

Luuze offers a weight-loss approach and tool focused on reducing environmental, physiological, and mental "friction" rather than relying on willpower, including help with setting reasonable, gradual weight-loss goals. The site presents educational articles and guidance for individuals pursuing sustainable, long-term weight loss.

1 investor

LUX Infusion operates infusion centers and pharmacies that administer specialty intravenous and subcutaneous medications for patients with autoimmune disorders, neurological conditions, immune deficiencies, chronic infections, and other complex conditions. It provides clinical infusion therapy services delivered by trained care teams.

1 investor

LUX MED operates a network of private medical facilities in Poland, offering diagnostic imaging (MRI, CT, mammography, ultrasound, X-ray), laboratory testing, specialist physician consultations, and optical salons. It serves patients seeking outpatient healthcare and provides urgent medical assistance around the clock.

1 investor

LyfeMD is a virtual clinic offering personalized, evidence-based guidance on nutrition, mental wellness, and movement for patients managing IBD (Crohn's/colitis) and inflammatory arthritis. It provides nutrition planning, mental wellness support, health coaching, and patient education to complement patients' existing medical treatment.

1 investor

LyfPlus provides digital health solutions for hospitals, helping them optimize operations and improve service quality by modernizing paper-based health infrastructure.

1 investor

Lync Bio develops fourth-generation SMART ADC (antibody-drug conjugate) technology for oncology, leveraging proprietary dual-target conjugate design and payload engineering to improve tumor coverage, cellular response, and manufacturability.

1 investor

Lynd Clinical operates a network of clinical research sites in underserved rural and community markets, using technology and local partnerships to expand patient access to clinical trials. The company combines on-the-ground site development with AI-enabled infrastructure to make research populations more representative and accessible to pharmaceutical sponsors.

1 investor

Lyngo builds AI phone answering systems designed specifically for healthcare clinics, automating call handling and appointment booking while maintaining human oversight for patient care. The service operates 24/7 to reduce administrative burden on front desk teams and support clinic operations globally.

1 investor

Lynx Dx develops MyProstateScore 2.0 (MPS2), a urine test that analyzes 18 gene transcripts to predict the presence of clinically significant prostate cancer. The diagnostic can be run as a biomarker-only test or combined with clinical risk factors, generating individualized patient reports for healthcare providers.

1 investor

m-Path develops mobile assessment solutions that enable researchers and clinicians to transform research concepts into actionable insights. The company is a KU Leuven spin-off specializing in tools for the research and clinical trial sectors.

1 investor

A biotech company developing gene therapy treatments for neurodegenerative diseases. The company is led by a founder with extensive clinical and regulatory experience in cell and gene therapy, supported by advisors and board members with deep expertise in neurosurgery, clinical neuroscience, and gene therapy development.

1 investor

Mabel is a platform for Accountable Care Organizations (ACOs) and health plans that automates voluntary alignment, provider-based beneficiary outreach, health surveys, and CMS compliance reporting. It supports Medicare value-based care programs such as LEAD, ACO REACH, and GUIDE through automated campaign execution, response processing, analytics, and audit-ready communications.

1 investor

Mable is an Australian online marketplace that connects people seeking disability or aged care support with local independent support workers. Clients can find and book services such as daily living assistance, personal care, nursing, and allied health, and negotiate rates directly with workers.

1 investor

Mablouseblanche is an online medical appointment booking platform that lets patients find and book nearby doctors, pharmacists, dentists and other health professionals. It also offers health professionals a low-cost connected medical scheduling tool, positioned as a cheaper alternative to existing booking software in France.

1 investor